The path of least resistance: aggressive or moderate treatment?

The evolution of resistance to antimicrobial chemotherapy is a major and growing cause of human mortality and morbidity. Comparatively little attention has been paid to how different patient treatment strategies shape the evolution of resistance. In particular, it is not clear whether treating indiv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kouyos, Roger D., Metcalf, C. Jessica E., Birger, Ruthie, Klein, Eili Y., Abel zur Wiesch, Pia, Ankomah, Peter, Arinaminpathy, Nimalan, Bogich, Tiffany L., Bonhoeffer, Sebastian, Brower, Charles, Chi-Johnston, Geoffrey, Cohen, Ted, Day, Troy, Greenhouse, Bryan, Huijben, Silvie, Metlay, Joshua, Mideo, Nicole, Pollitt, Laura C., Read, Andrew F., Smith, David L., Standley, Claire, Wale, Nina, Grenfell, Bryan
Formato: Artigo
Idioma:Inglês
Publicado: The Royal Society 2014
Assuntos:
Review Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211439/
https://ncbi.nlm.nih.gov/pubmed/25253451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rspb.2014.0566
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares